Drugs / RSV sF
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02115815 | Apr 2014 → Jun 2015 | respiratory syncytial virus infectious disease | MedImmune LLC | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RSV sF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02115815 ↗ |
| Route | Intramuscular | “by intramuscular injection” NCT02115815 ↗ |